Akineton and neuroleptic malignant syndrome Patient Reports February 11, 2012

Akineton Side Effects Report #5657350-0
Akineton side effect was reported by a Consumer or non-health professional from JAPAN on Mar 03, 2008. Female patient, 72 years of age, weighting 88.18 lb, was diagnosed with depression  and was treated with Akineton. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, dehydration, labile blood pressure, nausea , neuroleptic malignant syndrome, pyrexia, rhabdomyolysis. Akineton dosage: 3 MG/DAY. During the same period patient was treated with BLOPRESS, MEVALOTIN, UBRETID, DEPAS, MAGNESIUM OXIDE, ANAFRANIL, SERENACE, LUDIOMIL. Patient was hospitalized. Patient recovered.

Akineton Side Effects Report #5266168-2
Akineton side effect was reported by a Consumer or non-health professional from JAPAN on Mar 07, 2007. Male patient, 70 years of age, was treated with Akineton. After drug was administered, patient experienced the following side effects: neuroleptic malignant syndrome, renal failure acute, rhabdomyolysis. Akineton dosage: unknown. During the same period patient was treated with SULPIRIDE, RISPERIDONE, CHLORPROMAZINE HYDROCHLORIDE, PROMETHAZINE, PHENOBARBITAL, FLUNITRAZEPAM. Patient was hospitalized. Patient recovered.

Akineton Side Effects Report #5274986-X
Akineton side effect was reported by a Consumer or non-health professional from JAPAN on Mar 19, 2007. Male patient, 70 years of age, was treated with Akineton. After drug was administered, patient experienced the following side effects: neuroleptic malignant syndrome, renal failure acute, rhabdomyolysis. Akineton dosage: unknown. During the same period patient was treated with SULPIRIDE, RISPERIDONE, CHLORPROMAZINE HYDROCHLORIDE, PROMETHAZINE, PHENOBARBITAL, FLUNITRAZEPAM. Patient was hospitalized. Patient recovered.

Akineton Side Effects Report #5889646-1
Akineton side effect was reported by a Consumer or non-health professional from ITALY on May 16, 2008. Female patient, 64 years of age, was diagnosed with confusional state, alcohol detoxification, bipolar disorder  and was treated with Akineton. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, confusional state, hypernatraemia, metabolic acidosis, neuroleptic malignant syndrome, pyrexia. Akineton dosage: unknown. During the same period patient was treated with HALOPERIDOL, DISULFIRAM, CLOTIAPINE, LORAZEPAM, LITHIUM CARBONATE, VENLAFAXINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.


Akineton Side Effects Report #6083603-0
Akineton side effect was reported by a Consumer or non-health professional from ITALY on Feb 02, 2009. Female patient, 64 years of age, was diagnosed with confusional state, alcohol detoxification, bipolar disorder  and was treated with Akineton. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, confusional state, hypernatraemia, metabolic acidosis, neuroleptic malignant syndrome, pyrexia. Akineton dosage: unknown. During the same period patient was treated with HALOPERIDOL, ANTABUSE, ETUMINA, ORFIDAL, LITHIUM CARBONATE, VENLAFAXINE. Patient was hospitalized. Patient recovered.

Akineton Side Effects Report #4952674-4
Akineton side effect was reported by a Physician from JAPAN on Mar 13, 2006. Male patient, 62 years of age, was diagnosed with obsessive-compulsive disorder  and was treated with Akineton. After drug was administered, patient experienced the following side effects: influenza serology positive, neuroleptic malignant syndrome, pyrexia, renal failure. Akineton dosage: unknown. During the same period patient was treated with HALOPERIDOL, QUETIAPINE FUMARATE, OSELTAMIVIR. Patient was hospitalized. Patient recovered.

Akineton Side Effects Report #5537736-5
Akineton side effect was reported by a Health Professional from JAPAN on Nov 29, 2007. Female patient, 51 years of age, was treated with Akineton. After drug was administered, patient experienced the following side effects: neuroleptic malignant syndrome. Akineton dosage: unknown. Patient recovered.

Akineton Side Effects Report #5920405-7
Akineton side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 09, 2008. Male patient, 50 years of age, was treated with Akineton. After drug was administered, patient experienced the following side effects: neuroleptic malignant syndrome. Akineton dosage: unknown. During the same period patient was treated with HALOPERIDOL, DROXIDOPA, QUETIAPINE FUMARATE, QUETIAPINE FUMARATE, PROMETHAZINE. Patient recovered.

Akineton Side Effects Report #5931627-3
Akineton side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 17, 2008. Male patient, 50 years of age, was treated with Akineton. After drug was administered, patient experienced the following side effects: neuroleptic malignant syndrome. Akineton dosage: unknown. During the same period patient was treated with HALOPERIDOL, DROXIDOPA, QUETIAPINE FUMARATE, QUETIAPINE FUMARATE, PROMETHAZINE. Patient recovered.


Akineton Side Effects Report #5934836-2
Akineton side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 24, 2008. Male patient, 50 years of age, was treated with Akineton. After drug was administered, patient experienced the following side effects: neuroleptic malignant syndrome. Akineton dosage: unknown. During the same period patient was treated with HALOPERIDOL, DROXIDOPA, QUETIAPINE FUMARATE, QUETIAPINE FUMARATE, PROMETHAZINE. Patient recovered.

Akineton Side Effects Report #5316762-5
Akineton side effect was reported by a Consumer or non-health professional from JAPAN on Apr 24, 2007. Female patient, 43 years of age, was treated with Akineton. After drug was administered, patient experienced the following side effects: neuroleptic malignant syndrome. Akineton dosage: unknown. During the same period patient was treated with PEROSPIRONE, TRIHEXYPHENIDYL HYDROCHLORIDE, FLUNITRAZEPAM, ARIPIPRAZOLE. Patient was hospitalized. Patient recovered.

Akineton Side Effects Report #5328014-8
Akineton side effect was reported by a Consumer or non-health professional from JAPAN on May 07, 2007. Female patient, 43 years of age, was treated with Akineton. After drug was administered, patient experienced the following side effects: neuroleptic malignant syndrome. Akineton dosage: unknown. During the same period patient was treated with PEROSPIRONE, TRIHEXYPHENIDYL HYDROCHLORIDE, FLUNITRAZEPAM, ARIPIPRAZOLE. Patient was hospitalized. Patient recovered.

Akineton Side Effects Report #5921302-3
Akineton side effect was reported by a Health Professional from JAPAN on Oct 08, 2008. Male patient, 38 years of age, was treated with Akineton. After drug was administered, patient experienced the following side effects: nervous system disorder, neuroleptic malignant syndrome. Akineton dosage: unknown. Patient recovered.

Akineton Side Effects Report #5279496-1
Akineton side effect was reported by a Consumer or non-health professional from JAPAN on Mar 19, 2007. Male patient, 37 years of age, was diagnosed with agitation and was treated with Akineton. After drug was administered, patient experienced the following side effects: neuroleptic malignant syndrome, renal failure acute, rhabdomyolysis. Akineton dosage: unknown. During the same period patient was treated with HALOPERIDOL, CHLORPROMAZINE, PROMETHAZINE, PHENOBARBITAL, FLUNITRAZEPAM. Patient was hospitalized. Patient recovered.


Akineton Side Effects Report #5802382-2
Akineton side effect was reported by a Health Professional from JAPAN on June 27, 2008. Female patient, 33 years of age, was treated with Akineton. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, multi-organ failure, neuroleptic malignant syndrome, sepsis . Akineton dosage: unknown. Patient died.